Novo Holdings acquires biopharma company Paratek for $462m

Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster its antimicrobial resistance (AMR) expertise.

Sep 23, 2023 - 20:00

Novo Holdings acquires biopharma company Paratek for $462m

Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster its antimicrobial resistance (AMR) expertise.

Read the original article

Tags:

Previous Article

Yale and Transcend wins US DoD grant for PTSD therapy

Glenmark Pharma to divest 75% stake in life sciences unit for $680m

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: What’s behind the recent surge in Apellis’ stock price? Growing confidence in the safety of its eye treatment

STAT+: What’s behind the recent surge in Apellis’ stock...

Aug 15, 2023

JPM Day 3 had a cautiously optimistic outlook

JPM Day 3 had a cautiously optimistic outlook

Jan 10, 2024

Gender-affirming surgeries tripled in the U.S. between 2016-2019, study finds

Gender-affirming surgeries tripled in the U.S. between ...

Aug 23, 2023